文献速递脊柱外科小儿骨科

儿童青少年后路脊柱融合术中预防性使用普瑞巴林:双盲安慰剂对照随机临床试验

Preemptive Pregabalin in Children and Adolescents Undergoing Posterior Instrumented Spinal Fusion: A Double-Blinded, Placebo-Controlled, Randomized Clinical Trial.
PubMed 文献 · J Bone Joint Surg Am · 2020-01-01

结果显示两组术后48小时累计羟考酮消耗无差异(中位数1.44 vs 1.50 mg/kg,p=0.433),疼痛评分亦无显著差异(p=0.196)。

要点

  • 围手术期普瑞巴林不减少青少年后路脊柱融合术后阿片消耗。
  • 普瑞巴林组与安慰剂组术后48小时累计羟考酮消耗无统计学差异。
  • 两组术后疼痛评分无显著差异,普瑞巴林未显示额外镇痛获益。

核心结论

  • 围手术期使用普瑞巴林不能降低青少年后路脊柱融合术后的阿片消耗或疼痛评分。

主要发现

  • 术后48小时累计羟考酮消耗每公斤体重两组无差异,普瑞巴林组中位数1.44 mg/kg(95%CI 1.32至1.67),安慰剂组1.50 mg/kg(95%CI 1.39至1.79),p=0.433。
  • 51例青少年特发性脊柱侧凸亚组分析结果一致,普瑞巴林组均值1.45 mg/kg(95%CI 1.24至1.65),安慰剂组1.59 mg/kg(95%CI 1.37至1.82),p=0.289。
  • 每小时羟考酮总消耗量(mg/kg/hr)在各时间点两组无差异(p=0.752)。
  • 术后疼痛评分两组无显著差异(p=0.196)。

关键数值与推荐

  • 普瑞巴林剂量为2 mg/kg每日两次,术前开始并持续至术后5天。
  • 主要结局为通过患者自控镇痛测量的阿片总消耗量。

临床怎么用

  • 对于接受后路脊柱融合的青少年,不应基于减少阿片消耗的预期而常规围手术期加用普瑞巴林。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pregabalin as part of a multimodal pain-management regimen has been shown to reduce opioid consumption after spinal surgery in adults but it is unclear whether this is also true in adolescents. Pregabalin has been found to have neuroprotective effects and therefore could have a positive impact on pain after spinal deformity surgery. We conducted a randomized, double-blinded, placebo-controlled clinical trial of adolescent patients undergoing spinal fusion to evaluate the short-term effects of pregabalin on postoperative pain and opioid consumption. METHODS: Adolescents with adolescent idiopathic scoliosis, Scheuermann kyphosis, or spondylolisthesis who were scheduled for posterior spinal fusion with all-pedicle-screw instrumentation were randomized to receive either pregabalin (2 mg/kg twice daily) or placebo preoperatively and for 5 days after surgery. The patients ranged from 10 to 21 years of age. The primary outcome was total opioid consumption as measured with use of patient-controlled analgesia. Postoperative pain scores and opioid-related adverse effects were evaluated. RESULTS: Sixty-three of 77 eligible patients were included and analyzed. Cumulative oxycodone consumption per kilogram did not differ between the study groups during the first 48 hours postoperatively, with a median of 1.44 mg/kg (95% confidence interval [CI],1.32 to 1.67 mg/kg) in the pregabalin group and 1.50 mg/kg (95% CI, 1.39 to 1.79 mg/kg) in the placebo group (p = 0.433). A subgroup analysis of 51 patients with adolescent idiopathic scoliosis showed the same result, with a mean of 1.45 mg/kg (95% CI, 1.24 to 1.65 mg/kg) in the pregabalin group and 1.59 mg/kg (95% CI, 1.37 to 1.82 mg/kg) in the placebo group (p = 0.289). Total oxycodone consumption per hour (mg/kg/hr) was not different between the groups over the time points (p = 0.752). The postoperative pain scores did not differ significantly between the groups (p = 0.196). CONCLUSIONS: The use of perioperative pregabalin does not reduce the postoperative opioid consumption or pain scores in adolescents after posterior spinal fusion surgery. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Helenius LL, Oksanen H, Lastikka M, et al. Preemptive Pregabalin in Children and Adolescents Undergoing Posterior Instrumented Spinal Fusion: A Double-Blinded, Placebo-Controlled, Randomized Clinical Trial. J Bone Joint Surg Am. 2020. PMID: 31770296. doi:10.2106/JBJS.19.00650

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。